| A Study in Healthy Men to Test Whether Zongertinib Influences the Amount of 4 Other Medicines (Dabigatran, Rosuvastatin, Metformin, and Furosemide) in the Blood (NCT06504862) | Boehringer Ingelheim | 2024-08-20 |
| ADSCs Therapy in Patients With CTD-ILD (NCT06574581) | China Medical University Hospital | 2024-08-20 |
| A Clinial Trial of Lutetium [177Lu]-FAP-75 for the Treatment of Patients With Advanced Solid Tumors (NCT06553846) | Fudan University | 2024-08-19 |
| Trial to Investigate GZ21T in Healthy Volunteers (NCT06888362) | Genzada Pharmaceuticals USA, Inc. | 2024-08-19 |
| Study to Assess CMR316 in Healthy Volunteers and Patients With Idiopathic Pulmonary Fibrosis (NCT06589219) | Calibr, a division of Scripps Research | 2024-08-19 |
| Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial) (NCT06371417) | Chugai Pharmaceutical | 2024-08-19 |
| A Study Assessing the Safety and Tolerability of LY03020 in Chinese Healthy Subjects (NCT06556966) | Luye Pharma Group Ltd. | 2024-08-19 |
| A Phase I PK/PD Study of PEG-MetHuG-CSF (P2203) in Healthy Volunteers (NCT06698861) | PharmaEssentia | 2024-08-19 |
| Study to Assess the Safety, Tolerability, and Preliminary Efficacy of ST266 in Infants With Necrotizing Enterocolitis (NEC) (NCT06315738) | Noveome Biotherapeutics, formerly Stemnion | 2024-08-19 |
| EC-104 Intravitreal Implant for the Treatment of Diabetic Macular Edema (NCT06536491) | Eclipse Life Sciences, Inc. | 2024-08-19 |
| L9LS MAb in Malian Infants (NCT06461026) | National Institute of Allergy and Infectious Diseases (NIAID) | 2024-08-19 |
| Study of Safety and Efficacy of RGT-61159 in Adults With Relapsed/Refractory Adenoid Cystic Carcinoma (ACC) or Colorectal Carcinoma (CRC) (NCT06462183) | Rgenta Therapeutics Inc | 2024-08-19 |
| Phase I PK Study of Budesonide/Albuterol Delivered From PT027 in Healthy Chinese Participants. (NCT06514157) | AstraZeneca | 2024-08-19 |
| A Study to Evaluate the Effects of Phenytoin and Itraconazole on Sonrotoclax (BGB-11417) in Healthy Volunteers (NCT06543043) | BeiGene | 2024-08-19 |
| A Study of IBI3004 in Subjects With Unresectable, Locally Advanced or Metastatic Solid Tumors (NCT06198426) | Innovent Biologics (Suzhou) Co. Ltd. | 2024-08-19 |
| A Study to Test How Different Doses of BI 1815368 Are Tolerated and How BI 1815368 is Taken up in the Body of Healthy Japanese Men (NCT06494774) | Boehringer Ingelheim | 2024-08-19 |
| DBM-1152A Inhalation Solution in Healthy Volunteers (NCT07439419) | Joincare Pharmaceutical Group Industry Co., Ltd | 2024-08-18 |
| Ultrasonic Neuromodulation for Treatment of Cognitive Impairment (NCT06135051) | University of Utah | 2024-08-18 |
| Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Exosomes for Parkinson's Disease (NCT05152394) | The Foundation for Orthopaedics and Regenerative Medicine | 2024-08-17 |
| Trial of JMKX003801 in Healthy Participants (NCT06549309) | Jemincare | 2024-08-17 |
| A Phase I Study to Assess the Safety,Tolerability, PK, PD, and Food Effect of HSK44459 in Healthy Subjects (NCT06858657) | Haisco Pharmaceutical Group Co., Ltd. | 2024-08-17 |
| A Study of LY3532226 in Participants With Obesity (NCT06557356) | Eli Lilly and Company | 2024-08-16 |
| To Compare the Pharmacokinetics and Safety After a Single Dose Administration of IN-G00002 and IN-R00002 in Healthy Adult Volunteers (NCT06725355) | HK inno.N Corporation | 2024-08-16 |
| A Study of HRS-9057 in Patients With Heart Failure and Volume Overload (NCT06506994) | Fujian Shengdi Pharmaceutical Co., Ltd. | 2024-08-16 |
| A Study to Learn About the Safety of BAY3283142 in People With Mild to Moderate High Blood Pressure (NCT06428825) | Bayer | 2024-08-16 |
| A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies (NCT05589896) | Ossium Health, Inc. | 2024-08-16 |
| A Drug-Drug Interaction (DDI) Study of HDM1002 With Rifampicin and Itraconazole in Healthy Subjects (NCT06562088) | Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. | 2024-08-16 |
| Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01) (NCT06395103) | Merck Sharp & Dohme LLC | 2024-08-16 |
| A Study of Intravesical FL115 Alone or in Combination With BCG in Non-Muscle Invasive Bladder Cancer (NCT07122414) | Suzhou Forlong Biotechnology Co., Ltd | 2024-08-16 |
| A Modular Phase 1/2 Study With CT7439 in Participants With Solid Malignancies (NCT06600789) | Carrick Therapeutics Limited | 2024-08-16 |
| A Study on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HRS-7249 Injection in Healthy Subjects (NCT06541457) | Fujian Shengdi Pharmaceutical Co., Ltd. | 2024-08-15 |
| A Study Evaluating Food Effect on Pharmacokinetics of HS-10518 (NCT06554548) | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 2024-08-15 |
| A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease (NCT06297590) | Eli Lilly and Company | 2024-08-15 |
| Clinical Study of FB1001 in Patients (NCT06506305) | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | 2024-08-15 |
| A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease (NCT06546670) | Novartis Pharmaceuticals | 2024-08-15 |
| A Study to Investigate Multiple Ascending Doses and Relative Bioavailability of AZD5004 in Healthy Participants (NCT06555822) | AstraZeneca | 2024-08-15 |
| A Clinical Study of SYS6023 in Patients With Advanced Solid Tumors (NCT07110883) | CSPC Megalith Biopharmaceutical Co.,Ltd. | 2024-08-15 |
| Elimination of Prostate Cancer Treatment Side Effects Using a Nutraceutical (NCT06643494) | Optimal Health Research | 2024-08-15 |
| Study to Assess Drug Levels and Safety of Golcadomide (BMS-986369) in Healthy Participants and Participants With Different Degrees of Hepatic Impairment (NCT06535399) | Celgene | 2024-08-15 |
| Evaluating the Safety, Tolerability, and Pharmacokinetics of Monoclonal Antibodies in Healthy Participants (NCT05959707) | HIV Vaccine Trials Network | 2024-08-14 |
| SMP-3124LP in Adults With Advanced Solid Tumors (NCT06526819) | Sumitomo Pharma America, Inc. | 2024-08-14 |
| A Phase I/II, Dose Finding and Optimization Study of [177Lu]Lu-NeoB in Combination With Capecitabine in Patients With GRPR+, ER+, HER2- Metastatic Breast Cancer After Progression on Previous Endocrine Therapy in Combination With a CDK4/6 Inhibitor. (NCT06247995) | Novartis Pharmaceuticals | 2024-08-14 |
| A Study to Compare the Relative Potency of Salbutamol Administered Via Metered Dose Inhalers (MDI) Containing Propellants HFA-152a to HFA-134a in Mild Asthmatics Aged 18 to 65 Inclusive (NCT06433921) | GlaxoSmithKline | 2024-08-14 |
| Eltanexor and Venetoclax in Relapsed or Refractory Myelodysplastic Syndrome and Acute Myeloid Leukemia (NCT06399640) | Vanderbilt-Ingram Cancer Center | 2024-08-14 |
| Effects of VMX-C001 on the Anticoagulant Effect of Different Forms of Heparin (NCT06517563) | VarmX B.V. | 2024-08-14 |
| TumorGlow Intraoperative Molecular Imaging (IMI) (NCT04723810) | University of Pennsylvania | 2024-08-14 |
| Testing the Addition of Sunitinib Malate to Lutetium Lu 177 Dotatate (Lutathera) in Pancreatic Neuroendocrine Tumors (NCT05687123) | National Cancer Institute (NCI) | 2024-08-14 |
| A Phase I Trial of Combination Gemcitabine and Nab-Sirolimus in Advanced Leiomyosarcomas or Advanced Soft-Tissue Sarcomas With TSC2 or TSC1 Loss-of-function Mutations or Deletions (NCT06308419) | M.D. Anderson Cancer Center | 2024-08-14 |
| A Study to Learn How Different Amounts of the Study Medicine Called PF-07940369 Are Tolerated and Act in the Body in Healthy Adults. (NCT06532383) | Pfizer | 2024-08-14 |
| Safety/Efficacy Study of CID-078 in Patients With Advanced Solid Tumor Malignancies (NCT06577987) | Circle Pharma | 2024-08-14 |
| Bioequivalence of IMP 08P1707F0 Relative to Pulmicort® (1.0 Mg/2 Ml Suspension) (NCT06595121) | Unither Pharmaceuticals, France | 2024-08-13 |
| A Study to Investigate Natural Killer Cell Engager (SAR443579) With Different Agents in Participants With Hematological Malignancies (NCT06508489) | Sanofi | 2024-08-13 |
| Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors (NCT06545942) | MOMA Therapeutics | 2024-08-13 |
| MSC EVs in Dystrophic Epidermolysis Bullosa (NCT04173650) | Aegle Therapeutics | 2024-08-13 |
| A Clinical Study Aiming to Assess Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of TRX-100 in Healthy Volunteers (NCT06757738) | Traws Pharma, Inc. | 2024-08-13 |
| Study of Therapeutic Efficacy of CAR-T Cell Therapy in Patients With MDR-SRNS (NCT06553898) | The Children's Hospital of Zhejiang University School of Medicine | 2024-08-13 |
| Linperlisib Combination With Obinutuzumab Frontline Treatment of Marginal Zone Lymphoma Patients (MZL) (NCT06592170) | The First Hospital of Jilin University | 2024-08-13 |
| Single and Multiple Dose and Food Effect Study to Evaluate the Safety, Tolerability and Pharmacokinetics of D-2570 Tablets in Healthy Subjects (NCT07275775) | InventisBio Co., Ltd | 2024-08-13 |
| Comparison of the Effect of Red Wine With Alcohol on Flow-mediated Dilation Versus Red Wine Without Alcohol (NCT06535620) | Instituto de Cardiologia de Santa Catarina | 2024-08-13 |
| Bioequivalence Study of Simvastatin 40 mg Film-coated Tablets in Healthy Thai Volunteers (NCT06178640) | International Bio service | 2024-08-13 |
| A Study of RSV-HMPV Bivalent Vaccine VXB-241 in Older Adults (NCT06556147) | Sanofi | 2024-08-13 |
| Phase Ib Study of Axatilimab in Combination With Olaparib in BRCA1/2 and PALB2- Associated Metastatic HER2-negative Breast Cancer (NCT06488378) | Dana-Farber Cancer Institute | 2024-08-13 |
| A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed/Refractory Hematologic Malignancies (NCT06492304) | CRISPR Therapeutics | 2024-08-13 |
| Evaluation of Vamorolone CYP3A4 Induction on Midazolam (a Sensitive CYP 3A4 Substrate) Pharmacokinetics (NCT06689527) | Santhera Pharmaceuticals | 2024-08-13 |
| A Study to Evaluate Skin and Plasma Pharmacokinetic of Multiple Doses of Povorcitinib After Oral Administration in Healthy Participants (NCT06505265) | Incyte Corporation | 2024-08-12 |
| A Study of HDM2005 in Patients With Relapsed/Refractory B-cell Lymphoma and Advanced Solid Tumor (NCT06615193) | Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. | 2024-08-12 |
| Metformin Repurposing in Oral Submucous Fibrosis: Unveiling In Vitro Signaling Pathways, Progressing to Clinical Trial (NCT06332612) | Ziauddin University | 2024-08-12 |
| Mind Matters; Unveiling the Impact of Digital Mental Health Intervention (DMHI) on Psychological Distress Among Youth (NCT06875557) | Fatima Jinnah Women University | 2024-08-12 |
| Study of Influenza Vaccines Containing an Additional H3 Antigen in Healthy Adult Participants 18 to 49 Years of Age and 60 Years of Age and Older (NCT06507553) | Sanofi Pasteur, a Sanofi Company | 2024-08-12 |
| MB-CART19.1 in Refractory SLE (NCT06189157) | Miltenyi Biomedicine GmbH | 2024-08-12 |
| ACTION: Trial of Adding Buprenorphine, CBT, and TMS to Improve Outcomes of Long-Term Opioid Therapy for Chronic Pain (NCT06442566) | Medical University of South Carolina | 2024-08-12 |
| Pilot - Resistance Exercise for Inpatient Treatment in T2D (NCT06547541) | Rigshospitalet, Denmark | 2024-08-12 |
| A Study in Chinese People With Overweight or Obesity to Test How Different Doses of Survodutide Are Taken up in the Body (NCT06492135) | Boehringer Ingelheim | 2024-08-12 |
| A Comparing Study Between SJ04 and Ovidrel® in Healthy Subjects (NCT06599528) | Suzhou Centergene Pharmaceuticals Co.,Ltd. | 2024-08-12 |
| A Trial of HRS-6209 in Combination With Fulvestrant, Letrozole, HRS-8080, or HRS-1358 in Breast Cancer Patients (NCT06555068) | Jiangsu HengRui Medicine Co., Ltd. | 2024-08-12 |
| Erectile Dysfunction Treatment Using Stem Cells (NCT06550752) | COR clinic of Regenerative Medicine | 2024-08-10 |
| Ketofol Versus Dexmedetomidine for Prevention of Emergence Delirium in Pediatric Patients Undergoing Squint Surgeries (NCT06545890) | Cairo University | 2024-08-10 |
| Role of Eplerenone in Reducing Recurrence of Atrial Fibrillation in Patients With Structural Heart Disease (NCT06556732) | Assiut University | 2024-08-10 |
| To Evaluate the Effect of Single Oral Dose of MY008211A Tablets on QTc Interval in Healthy Subjects (NCT06543459) | Wuhan Createrna Science and Technology Co., Ltd | 2024-08-10 |
| A Study of APG-2575 in Patients With Mild-to-moderate Systemic Lupus Erythematosus. (NCT06182969) | Ascentage Pharma Group Inc. | 2024-08-09 |
| Lithium for Parkinson's: an Extension Trial (NCT06592014) | State University of New York at Buffalo | 2024-08-09 |
| Clinical Pharmacology Study of MT-3534 in Healthy Adult Male Volunteers (NCT06482346) | Tanabe Pharma Corporation | 2024-08-09 |
| A Study of HRS-4642 in Combination With Antineoplastic Agents in Advanced Solid Tumors (NCT06520488) | Jiangsu HengRui Medicine Co., Ltd. | 2024-08-09 |
| A Research Study Investigating Safety and Concentration in the Blood After One Dose Tablet of the New Medicine Monlunabant in Healthy Weight Japanese and Caucasian Men (NCT06542536) | Novo Nordisk A/S | 2024-08-09 |
| Exploratory Study of Irinotecan Liposomes in Maintenance Therapy of Metastatic Colorectal Cancer (NCT06341309) | West China Hospital | 2024-08-09 |
| Safety and Efficacy of Umbilical Cord-derived Mesenchymal Stem Cell(MSC) Transplantation in the Treatment of Bronchopulmonary Dysplasia(BPD) in Premature Infants (NCT06788470) | The Children's Hospital of Zhejiang University School of Medicine | 2024-08-09 |
| A Single-Dose, Three-Way, Three-Sequence, Crossover BA Study of Azithromycin Oleogel (NCT05796362) | Brigham and Women's Hospital | 2024-08-08 |
| COVID-19 Omicron BA.5 Subvariant Dose Finding Infection Study (NCT06478420) | University of Oxford | 2024-08-08 |
| IASO-782 in Autoimmune Hematological Diseases (NCT06534021) | Shanghai IASO Biotechnology Co., Ltd | 2024-08-08 |
| Radiotherapy with Immunotherapy and Anti-Angiogenic Therapy for Advanced HER2-Negative Breast Cancer: a Single-Arm Study (NCT06890871) | Zhongnan Hospital | 2024-08-08 |
| Non-invasive Electrical Spinal Cord Stimulation To Restore Upper Extremity Function in Multiple Sclerosis (NCT06552611) | University of Washington | 2024-08-08 |
| Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of AZD0780 (NCT06576765) | AstraZeneca | 2024-08-08 |
| A Study to Evaluate Lenti-HPV-07 Immunotherapy Against HPV+ Cervical or Oropharyngeal Cancer (NCT06319963) | Theravectys S.A. | 2024-08-08 |
| A Study to Evaluate the Safety, Tolerability of INCB160058 in Participants With Myeloproliferative Neoplasms (NCT06313593) | Incyte Corporation | 2024-08-08 |
| Clinical Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of Intravitreal (IVT) Injection of ABI-110 (AAV2.N54-VEGF Trap) in Subjects With Neovascular (Wet) Age-Related Macular Degeneration (wAMD), Including Symptomatic Macular Polypoidal Choroidal Vasculopathy (PCV) (NCT06550011) | Avirmax Biopharma Inc | 2024-08-07 |
| M9466 Alone or in Combination in Advanced Solid Tumors (DDriver 501) (NCT06421935) | EMD Serono Research & Development Institute, Inc. | 2024-08-07 |
| First-in-human Study of MRT-6160 in Healthy Subjects (NCT06597799) | Monte Rosa Therapeutics, Inc | 2024-08-07 |
| Study of BLU-808 in Healthy Adult Participants (NCT06948032) | Blueprint Medicines Corporation | 2024-08-07 |
| A Study to Test How Well Healthy People Tolerate Spesolimab When Given in 2 Different Ways (NCT06520514) | Boehringer Ingelheim | 2024-08-07 |
| A Clinical Study of SHR-9539 in Patients With Multiple Myeloma (NCT06484777) | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | 2024-08-07 |